Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

← catalyst calendar

NCT05571839

Sponsored by Seagen, a wholly owned subsidiary of Pfizer (industry) · PFE — their whole pipeline →.

Phase
Phase 1
Status
Terminated
Study type
Interventional
Design
Na · None · Treatment
Enrollment
41actual
Sites
37
Countries
Canada, France, Germany +3

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Why the sponsor stopped it

The trial was terminated for strategic reasons. The decision was not based on any safety concerns.

As filed on the registry record, in the sponsor's own words.

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-01-03actualWhen the study began enrolling
Primary completion2026-06-01actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2026-06-01actualThe whole study's end, after follow-up
First posted2022-10-07actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-07-01actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Cutaneous Melanoma
  • Non-small Cell Lung Cancer
  • Colorectal Neoplasms
  • Pancreatic Neoplasms
  • Mesothelioma

Intervention

  • Drug: PF-08046049

Primary outcomes

what the primary-completion date above is the date OF
Number of participants with adverse events (AEs)
measured Through 30 days after the last study treatment; approximately 7 months
Number of participants with laboratory abnormalities
measured Through 30 days after the last study treatment; approximately 7 months
Number of participants with dose limiting toxicities
measured Up to 28 days

Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed